Epiminder
Epiminder is focused on transforming epilepsy management through its innovative Minder system, the first FDA-authorised implantable continuous EEG monitoring (iCEM) system. This technology provides continuous, long-term EEG monitoring, offering enhanced treatment planning and remote care capabilities for patients with drug-resistant epilepsy. Epiminder aims to improve the quality of life for epilepsy patients by providing actionable information regarding seizures and other EEG events.
Short position
Epiminder (ASX:EPI) has 0.01% of its shares on issue reported as short positions as of 21 Sept 2026, or about 19,014 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. EPI is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Epiminder (EPI) short interest history
EPI Short Interest History
- 30-day change
- +0.01pp
- 90-day change
- +0.01pp
- 1-year change
- —
- All-time high
- 0.01% (September 2026)
- All-time low
- 0.00% (December 2025)
Is EPI heavily shorted?
Not especially: 0.01% short interest is modest by ASX standards, ranking #585 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has EPI's short interest changed recently?
Over the past 30 days Epiminder's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.01% of shares on issue.
What is the highest EPI's short interest has been?
Since 2025, Epiminder's short interest peaked at 0.01% in September 2026 and bottomed at 0.00% in December 2025.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2025. See our methodology.